首页> 美国卫生研究院文献>British Journal of Cancer >Specificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signalling
【2h】

Specificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signalling

机译:Ebp1(ErbB3结合蛋白1)介导的雄激素受体信号转导抑制的特异性和调蛋白调节

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although ErbB receptors have been implicated in the progression of prostate cancer, little is known about proteins that may mediate their interactions with the androgen receptor (AR). Ebp1, a protein cloned via its association with the ErbB3 receptor, binds the AR and inhibits androgen-regulated transactivation of wild-type AR in COS cells. As the complement of coregulators in different cells are important for AR activity, we determined the effect of Ebp1 on AR function in prostate cancer cell lines. In addition, we examined the regulation of Ebp1 function by the ErbB3/4 ligand heregulin (HRG). In this study, we demonstrate, using several natural AR-regulated promoters, that Ebp1 repressed transcriptional activation of wild-type AR in prostate cancer cell lines. Downregulation of Ebp1 expression in LNCaP cells using siRNA resulted in activation of AR in the absence of androgen. Ebp1 associated with ErbB3 in LNCaP cells in the absence of HRG, but HRG induced the dissociation of Ebp1 from ErbB3. In contrast, HRG treatment enhanced both the association of Ebp1 with AR and also the ability of Ebp1 to repress AR transactivation. These studies suggest that Ebp1 is an AR corepressor whose biological activity can be regulated by the ErbB3 ligand, HRG.
机译:尽管ErbB受体与前列腺癌的发展有关,但对于可能介导其与雄激素受体(AR)相互作用的蛋白质知之甚少。 Ebp1是一种通过与ErbB3受体结合而克隆的蛋白,它结合AR,并抑制COS细胞中野生型AR的雄激素调节反式激活。由于不同细胞中的核心调节剂的补体对AR活性很重要,因此我们确定了Ebp1对前列腺癌细胞系AR功能的影响。此外,我们检查了ErbB3 / 4配体调蛋白(HRG)对Ebp1功能的调节。在这项研究中,我们证明了使用几种天然的AR调控启动子,Ebp1抑制前列腺癌细胞系中野生型AR的转录激活。使用siRNA下调LNCaP细胞中Ebp1的表达导致雄激素不存在时AR的激活。在不存在HRG的情况下,LNCaP细胞中Ebp1与ErbB3相关,但是HRG诱导Ebp1从ErbB3分离。相反,HRG治疗既增强了Ebp1与AR的结合,又增强了Ebp1抑制AR反式激活的能力。这些研究表明,Ebp1是AR的抗抑郁药,其生物学活性可以由ErbB3配体HRG调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号